Early CRC drivers were found to be enriched in CRLM, which can harbor private mutations (PTPRT, and to a lesser degree, AMER1 and TCLF1), also suggesting stringent evolutionary selection mechanisms for the part of the CRLM [27] that is possibly governed by treatment [25]. The gene discussed is AMER1; the disease is colorectal carcinoma.